Catalyst Watch: Nvidia blockbuster, JPMorgan event, and reactions to the tariff reset
Source: SeekingAlpha
2026-02-20 15:00:23 ET
More on the markets
- VT: Still The Best Approach To Passive Investing
- U.S. GDP Set To Bounce Back After Government Shutdown Depresses Q4 Activity
- Why Static Portfolios Fail When Risk Regimes Change
- Trump says shutdown cut “at least two points" from GDP ahead of fourth quarter read
- SCOTUS ruling could put over $175B in U.S. tariff revenue at risk, Penn-Wharton estimates
Read the full article on Seeking Alpha
For further details see:
Catalyst Watch: Nvidia blockbuster, JPMorgan event, and reactions to the tariff reset
Eton Pharmaceutcials Inc.
NASDAQ: ETON
ETON Trading
3.66% G/L:
$17.43 Last:
65,545 Volume:
$16.69 Open:
ETON Latest News
March 03, 2026 04:30:00 pm
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
March 02, 2026 07:27:44 am
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
February 25, 2026 01:47:00 pm
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA(TM) (desmopressin acetate) Oral Solution
February 20, 2026 06:50:00 am
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
ETON Stock Data
$408,699,233
22,518,684
14.05%
24
N/A
Pharmaceuticals
Healthcare
US
Deer Park
